- POSITIVE
Quarterly Revenue Labcorp Jun-2026 Quarterly Revenue is $3,731 Million which is growth of 5.8% YoY.
- POSITIVE
Quarterly Net Profit Labcorp Jun-2026 Quarterly Net Profit is $299 Million which is growth of 25.6% YoY.
308.650.16(0.05%)
700.6K
XNYS Volume
XNYS 05 Oct, 2026 5:30 PM (EDT)
Labcorp quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents
Forecaster Analyst Estimates for Labcorp share price target, revenues, EPS, net income and more
Labcorp quarterly results: revenue, profit, and P&L – 13 quarter history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
Nested row level
Base Level
Export
| Indicator | Graph | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | Jun '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Rev. | 3,731.1 | 3,537.6 | 3,515.8 | 3,563.5 | 3,527.3 | 3,345.1 | 3,329.4 | 3,282 | 3,220.9 | 3,176.6 | 3,033.3 | 3,056.8 | 3,033.7 | |
Cost Of Rev. | 2,619.1 | 2,523.8 | 2,522.6 | 2,538.4 | 2,481.1 | 2,397.1 | 2,433.1 | 2,377.6 | 2,294.5 | 2,279.3 | 2,211.9 | 2,205.6 | 2,191.5 | |
Gross Profit | 1,112 | 1,013.8 | 993.2 | 1,025.1 | 1,046.2 | 948 | 896.3 | 904.4 | 926.4 | 897.3 | 821.4 | 851.2 | 842.2 | |
| 655.3 | 626.6 | 611.2 | 621.9 | 647.6 | 615.6 | 665.6 | 632.3 | 620 | 568.5 | 592.1 | 581.2 | 557.3 | ||
Operating Profit | 456.7 | 387.2 | 382 | 403.2 | 398.6 | 332.4 | 230.7 | 272.1 | 306.4 | 328.8 | 229.3 | 270 | 284.9 | |
| -61.1 | -55.1 | -55 | -56 | -57.1 | -56 | -63.4 | -50.4 | -47.6 | -46.9 | -48.8 | -50.3 | -49.8 | ||
Profit Before Tax | 386.4 | 319.7 | 190.6 | 337 | 304.7 | 275.2 | 183.8 | 210.6 | 267.7 | 297.4 | -147.1 | 238.7 | 205 | |
Tax | 87.3 | 41.7 | 25.7 | 75.5 | 66.4 | 62.2 | 40.2 | 41 | 62.1 | 69.1 | 19.7 | 55.1 | 49.8 | |
| 298.7 | 277.8 | 164.7 | 261.1 | 237.9 | 212.8 | 143.4 | 169.3 | 205.3 | 228 | -167.1 | 183.3 | 188.9 | ||
Diluted NI Avail to Com Stockholders Ann. | 298.7 | 277.8 | 164.7 | 261.1 | 237.9 | 212.8 | 143.4 | 169.3 | 205.3 | 228 | -167.1 | 183.3 | 188.9 | |
Basic EPS | 3.7 | 3.4 | 2 | 3.1 | 2.9 | 2.5 | 1.7 | 2 | 2.4 | 2.7 | -2 | 2.1 | 2.1 | |
Diluted EPS After ExtraOrdinary | 3.6 | 3.3 | 3.1 | 3.2 | 2.9 | 2.5 | 1.5 | 2.3 | 2.5 | 2.7 | 0.9 | 2.1 | 1.9 | |
Number Of Shares End | 81.7 | 82.3 | 82.6 | 83.1 | 83.4 | 83.6 | 83.6 | 84 | 84.1 | 84.1 | 84.7 | 86.6 | 88.7 | |
Net Income Continuing Discontinued Operations | 298.7 | 277.8 | 164.7 | 261.1 | 237.9 | 212.8 | 143.4 | 169.3 | 205.3 | 228 | -167.1 | 183.3 | 188.9 | |
Normalized Income | 298.3 | 272.8 | 260.7 | 263.5 | 239.8 | 212.7 | 129 | 190.6 | 213.2 | 229.5 | 77.3 | 183.8 | 165.7 | |
Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | |
Interest | 61.1 | 55.1 | 55 | 56 | 57.1 | 56 | 63.4 | 50.4 | 47.6 | 46.9 | 48.8 | 50.3 | 49.8 | |
Net Interest Income | -61.1 | -55.1 | -55 | -56 | -57.1 | -56 | -63.4 | -50.4 | -47.6 | -46.9 | -48.8 | -50.3 | -49.8 | |
EBIT | 447.5 | 374.8 | 245.6 | 393 | 361.8 | 331.2 | 247.2 | 261 | 315.3 | 344.3 | -98.3 | 289 | 254.8 | |
EBITDA | 626.5 | 548.1 | 418.6 | 564 | 532.1 | 498 | 417.8 | 422.5 | 472.2 | 498.8 | 48.1 | 434.9 | 373.9 | |
Reconciled Cost Of Rev. | 2,518.2 | 2,426.1 | 2,422.2 | 2,436.9 | 2,379.1 | 2,299.9 | 2,332.9 | 2,279.8 | 2,199.8 | 2,184.9 | 2,124.7 | 2,115.4 | 2,123.9 | |
Reconciled Depr. | 179 | 173.3 | 173 | 171 | 170.3 | 166.8 | 170.6 | 161.5 | 156.9 | 154.5 | 146.4 | 145.9 | 119.1 | |
Profit From Continuing Operations | 299.1 | 278 | 164.9 | 261.5 | 238.3 | 213 | 143.6 | 169.6 | 205.6 | 228.3 | -166.8 | 183.6 | 150.3 | |
Normalized EBITDA | 626 | 542.3 | 529.5 | 567.1 | 534.5 | 497.9 | 399.4 | 449 | 482.5 | 500.8 | 377.4 | 435.5 | 388 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Labcorp competitor comparison and performance snapshot within industry
Labcorp annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Annual Revenue Labcorp Dec-2025 Annual Revenue is $13,952 Million which is growth of 7.2% YoY.
- POSITIVE
Annual Net Profit Labcorp Dec-2025 Annual Net Profit is $876 Million which is growth of 17.5% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | TTM | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.1% | 0% | 13,951.7 | 13,008.9 | 12,161.6 | 14,876.8 | 16,120.9 | 13,978.5 | 11,554.8 | 11,333.4 | 10,441.4 | 9,641.8 | 8,680.1 | |||
Cost Of Rev. Ann. | -1.8% | 1.9% | 10,203.9 | 9,939.2 | 9,384.5 | 8,796.7 | 10,491.7 | 10,496.6 | 9,025.7 | 8,302.3 | 8,157 | 6,977.4 | 6,461.3 | 5,776.8 | |
Gross Profit Ann. | -2.9% | -4.1% | 4,144.1 | 4,012.5 | 3,624.4 | 3,364.9 | 4,385.1 | 5,624.3 | 4,952.8 | 3,252.5 | 3,176.4 | 3,464 | 3,180.5 | 2,903.3 | |
Operating Exp. Ann. | 3.4% | 4.5% | 2,515 | 2,496.3 | 2,486.4 | 2,241.2 | 2,255.9 | 2,321.7 | 2,004.7 | 1,867.7 | 1,802.6 | 2,028.9 | 1,809.7 | 1,786.5 | |
Operating Profit Ann. | -10.7% | -12.5% | 1,629.1 | 1,516.2 | 1,138 | 1,123.7 | 2,129.2 | 3,302.6 | 2,948.1 | 1,384.8 | 1,373.8 | 1,435.1 | 1,370.8 | 1,116.8 | |
- | - | -227.2 | -224.1 | -208.3 | -199.6 | -180.3 | -212.1 | -207.4 | -240.7 | -244.2 | -235.1 | -219.1 | -274.9 | ||
Other Exp. Ann. | - | - | -184.6 | 29.8 | -355.2 | -366.3 | 36.1 | -521.6 | -39.2 | 138.7 | -65.1 | -46.2 | -109.8 | ||
PBT Ann. | -11.2% | -13% | 1,233.7 | 1,107.5 | 959.5 | 568.9 | 1,582.6 | 3,126.6 | 2,219.1 | 1,104.9 | 1,268.3 | 1,134.9 | 1,105.5 | 732.1 | |
Tax Ann. | -8.7% | -19.1% | 230.2 | 229.8 | 212.4 | 188.5 | 302 | 747.1 | 662.1 | 280 | 384.4 | -139.1 | 372.3 | 294.1 | |
-11.8% | -10.8% | 1,002.3 | 876.5 | 746 | 418 | 1,279.1 | 2,377.3 | 1,556.1 | 823.8 | 883.7 | 1,268.2 | 732.1 | 436.9 | ||
Diluted NI Avail to Com Stockholders Ann. | -11.8% | -10.8% | 1,002.3 | 876.5 | 746 | 418 | 1,279.1 | 2,377.3 | 1,556.1 | 823.8 | 883.7 | 1,268.2 | 732.1 | 436.9 | |
EPS Ann. | -9.4% | -8.1% | 10.5 | 8.9 | 4.8 | 14.1 | 24.6 | 16 | 8.4 | 8.7 | 12.4 | 7.1 | 4.4 | ||
Diluted EPS Ann. | -9.1% | -8% | 10.5 | 8.8 | 4.8 | 14 | 24.4 | 15.9 | 8.4 | 8.6 | 12.2 | 7 | 4.3 | ||
Number Of Shares End | -2.3% | -3.2% | 82.6 | 83.6 | 84.7 | 88.7 | 95.5 | 97.3 | 97.3 | 100.2 | 102.4 | 103.1 | 101.5 | ||
Total Exp. Ann. | -0.8% | 2.4% | 12,435.5 | 11,870.9 | 11,037.9 | 12,747.6 | 12,818.3 | 11,030.4 | 10,170 | 9,959.6 | 9,006.3 | 8,271 | 7,563.3 | ||
Net Income Continuing Discontinued Operations Ann. | -11.8% | -10.8% | 1,002.3 | 876.5 | 746 | 418 | 1,279.1 | 2,377.3 | 1,556.1 | 823.8 | 883.7 | 1,268.2 | 732.1 | 436.9 | |
Normalized Income Ann. | -14.7% | -12.6% | 1,095.2 | 968.7 | 768.6 | 626.3 | 1,559.7 | 2,402.3 | 1,901.8 | 858 | 912 | 1,309.5 | 769.7 | 504.1 | |
Interest Income Ann. | - | - | - | - | - | - | - | - | - | - | - | - | - | ||
Interest Ann. | 7.5% | 1.6% | 227.2 | 224.1 | 208.3 | 199.6 | 180.3 | 212.1 | 207.4 | 240.7 | 244.2 | 235.1 | 219.1 | 274.9 | |
EBITDA Ann. | -5.7% | -8% | 2,157.2 | 2,012.7 | 1,811.3 | 1,345.8 | 2,396.8 | 4,083.8 | 3,051.2 | 1,922.8 | 2,064.6 | 1,903.2 | 1,823.8 | 1,464.8 | |
Reconciled Cost Of Rev. Ann. | -1.9% | 1.9% | 9,803.4 | 9,538.1 | 8,997.4 | 8,439.2 | 10,117.1 | 10,121.1 | 8,676.4 | 7,968.3 | 7,836.6 | 6,660.7 | 6,141.6 | 5,483.5 | |
Reconciled Depr. Ann. | 2.4% | 1.7% | 696.3 | 681.1 | 643.5 | 577.3 | 633.9 | 745.1 | 624.7 | 577.2 | 552.1 | 533.2 | 499.2 | 457.8 | |
Profit From Continuing Operations Ann. | -11.8% | -10.8% | 1,003.5 | 877.7 | 747.1 | 380.4 | 1,280.6 | 2,379.5 | 1,557 | 824.9 | 883.9 | 1,274 | 733.2 | 438 | |
Normalized EBITDA Ann. | -8.1% | -9.7% | 2,264.9 | 2,129 | 1,840.3 | 1,715.1 | 2,743.2 | 4,116.7 | 3,543.6 | 1,968.6 | 2,105.2 | 1,972 | 1,880.5 | 1,576.8 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Rev. Ann.
1Y CHG
7.2%
2Y CAGR
7.1%
3Y CAGR
-2.1%
5Y CAGR
0%
7Y CAGR
3%
10Y CAGR
4.9%
Total Revenue Annual growth is higher than historical averages.
Net Profit Ann.
1Y CHG
17.5%
2Y CAGR
44.8%
3Y CAGR
-11.8%
5Y CAGR
-10.8%
7Y CAGR
-0.1%
10Y CAGR
7.2%
Net Profit Annual growth is higher than historical averages.
Operating Exp. Ann.
1Y CHG
0.4%
2Y CAGR
5.5%
3Y CAGR
3.4%
5Y CAGR
4.5%
7Y CAGR
4.8%
10Y CAGR
3.4%
Operating Expenses Annual Cr growth is lower than historical averages.
Labcorp balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Total Shareholders Fund Labcorp Dec-2025 Total Shareholders Fund is $8,620 Million which is growth of 7.0% YoY.
- POSITIVE
Total Assets Labcorp Dec-2025 Total Assets is $18,393 Million which is growth of 0.1% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-3% | -1.7% | 18,392.7 | 18,379 | 16,725.1 | 20,155.1 | 20,385.4 | 20,071.7 | 18,046.4 | 16,185.3 | 16,568 | 14,247 | 14,221.7 | ||
-1% | -1.8% | 9,756 | 10,312.5 | 8,834.6 | 10,039.6 | 10,091.4 | 10,691.3 | 10,459.3 | 9,194.8 | 9,717.2 | 8,726 | 9,262.4 | ||
-5.1% | -1.6% | 8,619.8 | 8,052.2 | 7,875 | 10,096.6 | 10,273.4 | 9,359.7 | 7,567 | 6,971.4 | 6,830 | 5,505.8 | 4,944.4 | ||
Total Capitalization Ann. | -3.3% | -1.5% | 13,704.4 | 13,383.4 | 11,929.7 | 15,135.4 | 15,689.9 | 14,778.7 | 13,356.8 | 12,962.3 | 13,116.8 | 10,742.4 | 10,881 | |
Tangible Assets Ann. | - | - | -1,765.7 | -1,806.4 | -1,609.5 | -1,971.3 | -1,421 | -2,352.9 | -4,332.5 | -4,300 | -5,040.8 | -4,319.1 | -4,606.8 | |
Working Capital Ann. | -8.2% | -10.2% | 1,197 | 1,476.3 | 540.2 | 1,546.5 | 2,547.6 | 2,046.9 | 325.4 | 956.5 | 636.5 | 651.1 | 961.5 | |
Invested Capital Ann. | -2.7% | -1.3% | 14,204.5 | 14,383.7 | 12,929.5 | 15,436.7 | 15,691.4 | 15,155.4 | 13,772 | 12,972.3 | 13,526 | 11,283.5 | 11,300.5 | |
Tangible Book Value Ann. | - | - | -1,765.7 | -1,806.4 | -1,609.5 | -1,971.3 | -1,421 | -2,352.9 | -4,332.5 | -4,300 | -5,040.8 | -4,319.1 | -4,606.8 | |
Borrowings Ann. | 1.2% | -0.7% | 6,526 | 7,272.8 | 5,954.2 | 6,294.9 | 6,342.6 | 6,756.4 | 7,107.6 | 6,059.8 | 6,762.1 | 5,849.5 | 6,417 | |
Net Debt Ann. | 1% | 2.5% | 5,052.4 | 4,812.8 | 4,517.7 | 4,910.1 | 3,945.3 | 4,474.9 | 5,867.5 | 5,574.1 | 6,379.3 | 5,344.1 | 5,639.7 | |
Share Issued Ann. | -2.3% | -3.4% | 82.2 | 83.4 | 83.9 | 88.2 | 93.1 | 97.5 | 97.2 | 122.4 | 125.1 | 125.6 | 123.9 | |
Number Of Shares End | -2.3% | -3.2% | 82.6 | 83.6 | 84.7 | 88.7 | 95.5 | 97.3 | 97.3 | 100.2 | 102.4 | 103.1 | 101.5 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Total Assets Ann.
1Y CHG
0.1%
2Y CAGR
4.9%
3Y CAGR
-3%
5Y CAGR
-1.7%
7Y CAGR
1.8%
10Y CAGR
2.6%
Total Assets Annual growth is stable compared to historical averages.
Total Current Liabilities Ann.
1Y CHG
-15.2%
2Y CAGR
-6.4%
3Y CAGR
-2.8%
5Y CAGR
-1.7%
7Y CAGR
6%
10Y CAGR
5.2%
Total Current Liabilities Annual Cr is falling faster than historical averages.
Total ShareHolders Funds Ann.
1Y CHG
7%
2Y CAGR
4.6%
3Y CAGR
-5.1%
5Y CAGR
-1.6%
7Y CAGR
3.1%
10Y CAGR
5.7%
Total ShareHolders Funds Annual growth is higher than historical averages.
Labcorp ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Book Value Per Share Labcorp Book Value Per Share is $106 which is growth of 4.1% YoY.
- NEUTRAL
ROE Labcorp ROE is 0% which is growth of 0% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RoA Ann. % | - | - | - | 4.25% | 2.27% | 6.31% | 11.75% | 8.16% | 4.81% | 5.40% | 8.23% | 5.14% | 4.06% | |
ROE Ann. % | - | - | - | 9.37% | 4.65% | 12.56% | 24.22% | 18.39% | 11.33% | 12.81% | 20.56% | 14.01% | 11.25% | |
ROIC % | - | - | - | 1.2 | -0.9 | 0.7 | 3.5 | 6.3 | 1.9 | 1.5 | 5.6 | 1.9 | 1.3 | |
OPM Ann. % | -8.8% | -12.4% | 10.87% | 8.75% | 9.24% | 14.31% | 20.49% | 21.09% | 11.98% | 12.12% | 13.74% | 14.22% | 12.87% | |
Inventory Turnover Ratio Ann. | - | - | - | 19.4 | 18.6 | 24.1 | 25.5 | 27 | 34.5 | 35.1 | 32.2 | 32.6 | 35 | |
Asset Turnover Ann. % | - | - | - | 0.7 | 0.7 | 0.7 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
Working Capital Turnover Ann. | 6.8% | 11.5% | 11.7 | 8.8 | 22.5 | 9.6 | 6.3 | 6.8 | 35.5 | 11.9 | 16.4 | 14.8 | 9 | |
Quick Ratio Ann. | - | - | - | 1.1 | 0.8 | 1.1 | 1.6 | 1.4 | 0.9 | 1.2 | 1 | 1.1 | 1.2 | |
Current Ratio Ann. | - | - | - | 1.4 | 1.2 | 1.5 | 1.9 | 1.7 | 1.1 | 1.5 | 1.3 | 1.4 | 1.6 | |
Interest Coverage Ratio Ann. | - | - | - | 5.6 | 3.9 | 9.8 | 15.7 | 11.7 | 5.6 | 6.2 | 5.8 | 6.1 | 3.7 | |
LT Debt To Equity Ann. | - | - | - | 0.8 | 0.6 | 0.6 | 0.6 | 0.7 | 0.9 | 0.9 | 0.9 | 1 | 1.2 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Labcorp cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history
Nested row level
Base Level
Reporting Type
Originally Reported
Cell Data
Actual
Table Settings
YoY & New to Old
CAGR Columns
Select...
Nested row level
Base Level
Export
- POSITIVE
Cash From Operating Activity Labcorp Dec-2025 Cash From Operating Activity is $1,640 Million which is growth of 3.4% YoY.
- NEGATIVE
Net Cash Flow Labcorp Dec-2025 Net Cash Flow is $-1,010 Million which is growth of -201.2% YoY.
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-5.7% | -5.1% | 1,640.5 | 1,585.8 | 1,202.3 | 1,955.9 | 3,109.6 | 2,135.3 | 1,444.7 | 1,305.4 | 1,459.4 | 1,175.9 | 982.4 | ||
- | - | -1,194 | -1,366.8 | -1,146.8 | -1,652.2 | -884.6 | -643.2 | -1,283.1 | 206.7 | -2,228.7 | -795.7 | -3,994.9 | ||
- | - | -1,457 | 779.9 | -1,559 | -1,322.2 | -2,065.8 | -517.4 | -252.7 | -1,389.9 | 631.9 | -649.8 | 3,184.6 | ||
Cash Plus Cash Eqv. End Of Year Ann. | 7.4% | -16.6% | 532.3 | 1,518.7 | 536.8 | 430 | 1,472.7 | 1,320.8 | 337.5 | 426.8 | 316.7 | 433.6 | 716.4 | |
Net Increase In Cash Plus Cash Eqv.s Ann. | - | - | -1,010.5 | 998.9 | 96.9 | -1,018.5 | 159.2 | 974.7 | -91.1 | 122.2 | -137.4 | -269.6 | 172.1 | |
Cash Plus Cash Eqv. Begin Of Year Ann. | 1% | 35.1% | 1,518.7 | 536.8 | 430 | 1,472.7 | 1,320.8 | 337.5 | 426.8 | 316.6 | 433.6 | 716.4 | 580 | |
Income Tax Paid Supplemental Data Ann. | -30.3% | - | 171.1 | 215.4 | 206.8 | 504.7 | - | - | - | 349.7 | 348 | 345.7 | 249.4 | |
Interest Paid Supplemental Data Ann. | 3.4% | - | 217.7 | 209.2 | 221.5 | 197.1 | - | - | - | 296.2 | 239.1 | 210.7 | 166.1 | |
Capex Ann. | - | - | -434.5 | -489.9 | -453.6 | -481.9 | -460.4 | -381.7 | -400.2 | -379.8 | -315.4 | -278.9 | -255.8 | |
Issuance Of Capital Stock Ann. | - | - | - | - | 54.4 | 50.6 | 51.7 | 55.9 | 64.7 | 69.1 | 73.6 | 70.6 | 98.9 | |
Issuance Of Debt Ann. | -56.5% | -15.6% | 64.8 | 4,463.7 | 2,488.2 | 787.4 | 1,000 | 151.7 | 2,395 | 467.2 | 3,342.2 | 139.5 | 4,360 | |
Repayment Of Debt Ann. | - | - | -1,064.8 | -3,463.7 | -2,788.2 | -787.4 | -1,375 | -563.9 | -2,184.9 | -1,171.8 | -2,426.9 | -806.3 | -1,250.6 | |
Repurchase Of Capital Stock Ann. | - | - | -450 | -250.1 | -1,000 | -1,100 | -1,668.5 | -100 | -450 | -700 | -338.1 | -43.9 | ||
Free Cash Flow Ann. | -6.5% | -7.2% | 1,206 | 1,095.9 | 874.1 | 1,474 | 2,649.2 | 1,753.6 | 1,044.5 | 925.6 | 1,144 | 897 | 726.6 |
*All financials are in USD Million and price data in USD
Add metric to table
Search...
Cash from Operating Act. Ann.
1Y CHG
3.4%
2Y CAGR
16.8%
3Y CAGR
-5.7%
5Y CAGR
-5.1%
7Y CAGR
3.3%
10Y CAGR
5.3%
Cash from Operating Activity Annual growth is higher than historical averages.
